Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth N Sclair

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Gastroenterology Reports|January 15, 2013
An update on the hepatitis E virusSeth N Sclair, Eugene R Schiff
Clinical and Translational Gastroenterology|August 28, 2015
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisSeth N Sclair, Ester Little, Cynthia Levy
Hepatology Communications|December 1, 2025
Semaglutide for metabolic dysfunction-associated steatohepatitis (MASH): Estimating eligibility from the 2021-2023 National Health and Nutrition Examination Survey (NHANES)Joel W Hughes, Jennifer B Levin, Martha Sajatovic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2015
Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver DiseaseMasato Yoneda, Emmanuel Thomas, Seth N Sclair, et al.
Clinics in Liver Disease|June 30, 2024
Porto-sinusoidal Vascular Disease and Portal HypertensionSarah Noble, Marguerite Linz, Eduardo Correia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevirEmerson Y Chen, Seth N Sclair, Frank Czul, et al.
Clinical Transplantation|March 31, 2016
Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantationSeth N Sclair, Maria Isabel Fiel, Hai-Shan Wu, et al.
Digestive Diseases and Sciences|June 13, 2016
Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health SystemsSeth N Sclair, Olveen Carrasquillo, Frank Czul, et al.
Journal of Clinical Gastroenterology|October 19, 2020
Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National StudyNahel A Tunio, Emad Mansoor, Mohammed Z Sheriff, et al.
Digestive Diseases and Sciences|October 7, 2014
Low SVR rates in clinical practice for treating genotype 1 chronic hepatitis C with protease inhibitors boceprevir and telaprevirPerry H Dubin, Seth N Sclair, Rene Rico, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Gastroenterology Reports|January 15, 2013
An update on the hepatitis E virusSeth N Sclair, Eugene R Schiff
Clinical and Translational Gastroenterology|August 28, 2015
Current Concepts in Primary Biliary Cirrhosis and Primary Sclerosing CholangitisSeth N Sclair, Ester Little, Cynthia Levy
Hepatology Communications|December 1, 2025
Semaglutide for metabolic dysfunction-associated steatohepatitis (MASH): Estimating eligibility from the 2021-2023 National Health and Nutrition Examination Survey (NHANES)Joel W Hughes, Jennifer B Levin, Martha Sajatovic, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 26, 2015
Supersonic Shear Imaging and Transient Elastography With the XL Probe Accurately Detect Fibrosis in Overweight or Obese Patients With Chronic Liver DiseaseMasato Yoneda, Emmanuel Thomas, Seth N Sclair, et al.
Clinics in Liver Disease|June 30, 2024
Porto-sinusoidal Vascular Disease and Portal HypertensionSarah Noble, Marguerite Linz, Eduardo Correia, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2013
A small percentage of patients with hepatitis C receive triple therapy with boceprevir or telaprevirEmerson Y Chen, Seth N Sclair, Frank Czul, et al.
Clinical Transplantation|March 31, 2016
Increased hepatic progenitor cell response and ductular reaction in patients with severe recurrent HCV post-liver transplantationSeth N Sclair, Maria Isabel Fiel, Hai-Shan Wu, et al.
Digestive Diseases and Sciences|June 13, 2016
Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health SystemsSeth N Sclair, Olveen Carrasquillo, Frank Czul, et al.
Journal of Clinical Gastroenterology|October 19, 2020
Epidemiology of Autoimmune Hepatitis (AIH) in the United States Between 2014 and 2019: A Population-based National StudyNahel A Tunio, Emad Mansoor, Mohammed Z Sheriff, et al.
Digestive Diseases and Sciences|October 7, 2014
Low SVR rates in clinical practice for treating genotype 1 chronic hepatitis C with protease inhibitors boceprevir and telaprevirPerry H Dubin, Seth N Sclair, Rene Rico, et al.
Pageof 2